Condition
Blood Cancers
Total Trials
5
Recruiting
4
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Recruiting4
Withdrawn1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07148180Phase 1Recruiting
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
NCT06296368Not ApplicableRecruiting
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
NCT01166009Recruiting
CIBMTR Research Database
NCT07058571Not ApplicableRecruitingPrimary
Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention
NCT06543511Not ApplicableWithdrawn
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
Showing all 5 trials